Why Invest in Brazil | Multinational Stock Exposure
Global capital flowing into Brazil's key sectors may create significant economic opportunities for the nation's growth. This basket offers exposure to these trends through US and EU-listed multinational corporations that have a substantial presence in the Brazilian economy.
Your Basket's Financial Footprint
This basket's total market capitalisation is 805,358.1659999999 and is anchored by several very large-cap holdings, indicating concentration in established firms.
- Large-cap dominance generally implies lower volatility and a closer fit to broad market performance.
- Use this basket as a core, long-term holding rather than a speculative or high‑beta trade.
- Expect steady, long-term value capture rather than rapid, short-term, explosive gains.
VALE: $51.43B
PBR: $73.85B
MELI: $106.57B
- Other
About This Group of Stocks
Our Expert Thinking
Brazil's economic expansion and massive consumer base present compelling investment opportunities. Global capital is flowing into key sectors like agribusiness and energy, where Brazil holds significant competitive advantages. This collection captures these trends through established multinational corporations with deep operational roots in the Brazilian market.
What You Need to Know
This group focuses on US and EU-listed companies rather than direct Brazilian stocks, providing exposure to Brazil's growth through established global players. These firms span diverse industries from commodities and finance to telecommunications and retail, all capitalising on Brazil's upward economic momentum and substantial foreign direct investment.
Why These Stocks
Each company was selected for its significant operational footprint, supply chains, or investment projects within Brazil. These aren't just companies that occasionally do business there - they're multinational leaders with substantial Brazilian operations, allowing investors to participate in the nation's development through proven industry giants.
Why You'll Want to Watch These Stocks
Economic Powerhouse Rising
Brazil's economy is attracting massive foreign investment flows, particularly in agribusiness and energy sectors where the country holds global leadership positions. These multinational companies are positioned to benefit from this economic expansion.
Massive Consumer Market
With over 215 million people, Brazil represents one of the world's largest consumer markets. These companies have established operations to serve this growing demand, from digital services to everyday consumer goods.
Strategic Global Players
Rather than taking direct exposure to Brazilian markets, this collection features established US and EU-listed multinationals with proven track records and significant Brazilian operations, offering a more accessible way to invest in Brazil's growth story.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Railroad Investment: Beyond the $85 Billion Merger
Union Pacific and Norfolk Southern are seeking to merge, creating America's first transcontinental railroad. This landmark consolidation could drive significant investment into rail infrastructure and technology, creating opportunities for companies that support and equip the freight rail industry.
Oracle TikTok Deal May Boost Stocks in 2025
TikTok has finalized the sale of its U.S. operations to an investor group including Oracle, resolving national security concerns and securing its future in the American market. This development creates opportunities for companies in the digital advertising, social commerce, and creator economy sectors that can now capitalize on the platform's stabilized presence and massive user base.
Pharma Reshoring Explained | Manufacturing Investment
Major pharmaceutical firms have signed agreements with the U.S. government to lower drug prices in exchange for tariff exemptions and other concessions. This move is expected to drive over $150 billion in new domestic R&D and manufacturing investments, creating opportunities for U.S.-based life sciences and industrial supply chain companies.